Skip to content

How to deliver good adherence support: lessons from round the world

$42 billion neded to achieve universal access by 2010, says UNAIDS

PrEP could prevent up to three million HIV infections in ten years in Africa

Urinary stones a rare side-effect of atazanavir

ICAAC: Gains in limb fat and CD4 counts continue three years after switching from d4T to tenofovir

ICAAC: Cross-resistance to 3TC and FTC develops slowly with entecavir monotherapy

Return of nelfinavir's European license recommended

ICAAC: Phase 1 study provides `proof of concept` for PRO 140, a monoclonal CCR5 antibody

ICAAC: No drug interactions found between TMC125 and ritonavir-boosted elvitegravir